Related Experiment Video
Updated: Jun 23, 2025
11:00
Visualization, Quantification, and Mapping of Immune Cell Populations in the Tumor Microenvironment
Published on: March 25, 2020
17.1K
Deciphering the tumor immune microenvironment from a multidimensional omics perspective: insight into next-generation
Zhaokai Zhou1,2, Jiahui Wang1,3, Jiaojiao Wang1
1Department of Pharmacy, The Second Xiangya Hospital, Central South University, Changsha, Hunan, 410011, China.
Molecular Cancer
|June 25, 2024
Summary
Understanding the tumor immune microenvironment (TIME) is key for improving chimeric antigen receptor (CAR)-T cell therapy in solid tumors. Multi-omics and machine learning reveal TIME factors to enhance CAR-T cell effectiveness.
Area of Science:
- Immunology
- Oncology
- Bioinformatics
Background:
- The tumor immune microenvironment (TIME) significantly influences cancer progression and treatment response.
- Chimeric antigen receptor (CAR)-T cell immunotherapy is highly effective for hematologic cancers but faces challenges in solid tumors due to TIME heterogeneity.
Purpose of the Study:
- To investigate factors shaping the TIME.
- To explore strategies for enhancing CAR-T cell immunotherapy efficacy in solid tumors using a multi-omics approach.
- To guide the development of personalized cancer therapies.
Main Methods:
- Review of current literature on TIME.
- Analysis of multi-omics data to understand TIME characteristics.
- Application of machine learning to identify immune resistance mechanisms.
Main Results:
- TIME heterogeneity is a major barrier to CAR-T cell therapy in solid tumors.
- Multi-omics and machine learning provide insights into TIME complexity and immune evasion.
- Targeting unfavorable TIME conditions can improve therapeutic outcomes.
Conclusions:
- A deeper understanding of TIME through advanced technologies is crucial.
- Personalized strategies targeting the TIME are needed to optimize CAR-T cell therapy for solid tumors.
Keywords:
Chimeric antigen receptor T cellImmunotherapyMachine learningMulti-omicsSolid tumorsTumor immune microenvironmentMore Related Videos
Related Concept Videos
01:27Tumor Immunotherapy
511
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
511
02:17The Tumor Microenvironment
6.6K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.6K